Radiological Response Is Associated with Better Long-Term Outcomes and Is a Potential Treatment Target in Patients with Small Bowel Crohn's Disease

American Journal of Gastroenterology

Volumn 111, Issue 7, 2016, Pages 997-1006

  Deepak, Parakkal ^a   Fletcher, Joel G ^b   Fidler, Jeff L ^b   Barlow, John M ^b   Sheedy, Shannon P ^b   Kolbe, Amy B ^b   Harmsen, William S ^b   Loftus, Edward V ^a   Hansel, Stephanie L ^a   Becker, Brenda D ^a   Bruining, David H ^a  

^a MAYO CLINIC   (United States)

^b Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARIUM; C REACTIVE PROTEIN; CONTRAST MEDIUM; CORTICOSTEROID; GADOLINIUM; GASTROINTESTINAL AGENT; GLUCOCORTICOID;

ADULT; ARTICLE; COHORT ANALYSIS; COMPUTED TOMOGRAPHY ENTEROGRAPHY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORTICOSTEROID THERAPY; CROHN DISEASE; DISEASE DURATION; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; IMAGING SOFTWARE; INTESTINE RADIOGRAPHY; MAGNETIC RESONANCE ENTEROGRAPHY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION RESPONSE; RETROSPECTIVE STUDY; SMALL BOWEL CROHN DISEASE; TERMINAL ILEUM; ABDOMINAL SURGERY; DIAGNOSTIC IMAGING; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; PATHOLOGY; PHYSIOLOGIC MONITORING; PROCEDURES; SMALL INTESTINE; STATISTICS AND NUMERICAL DATA; TIME; UNITED STATES; X-RAY COMPUTED TOMOGRAPHY;

ADULT; CROHN DISEASE; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; GASTROINTESTINAL AGENTS; GLUCOCORTICOIDS; HOSPITALIZATION; HUMANS; INTESTINE, SMALL; MAGNETIC RESONANCE IMAGING; MALE; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; MONITORING, PHYSIOLOGIC; RETROSPECTIVE STUDIES; TIME; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 84966587919     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2016.177     Document Type: Article

References (39)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 1991; 325: 928-37.
2. Cosnes J, Cattan S, Blain A et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002; 8: 244-50.
3. Peyrin-Biroulet L, Reinisch W, Colombel J-F et al. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial. Gut 2014; 63: 88-95.
4. Cellier C, Sahmoud T, Froguel E et al. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gut 1994; 35: 231-5.
5. D'Haens GR, Fedorak R, Lemann M et al. Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease. Inflamm Bowel Dis 2009; 15: 1599-604.
6. Frøslie KF, Jahnsen J, Moum BA et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 2007; 133: 412-22.
7. Bouguen G, Levesque BG, Feagan BG et al. Treat to target: a proposed new paradigm for the management of Crohn's disease. Clin Gastroenterol Hepatol 2013; 13: 1042-50.
8. Bouguen G, Levesque BG, Pola S et al. Endoscopic assessment and treating to target increase the likelihood of mucosal healing in patients with Crohn's disease. Clin Gastroenterol Hepatol 2014; 12: 978-85.
9. Peyrin-Biroulet L, Sandborn W, Sands B et al. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target. Am J Gastroenterol 2015; 110: 1324-38.
10. Terheggen G, Lanyi B, Schanz S et al. Safety, feasibility, and tolerability of ileocolonoscopy in inflammatory bowel disease. Endoscopy 2008; 40: 656-63.
11. Samuel S, Bruining DH, Loftus EV et al. Endoscopic skipping of the distal terminal ileum in Crohn's disease can lead to negative results from ileocolonoscopy. Clin Gastroenterol Hepatol 2012; 10: 1253-9.
12. Bruining DH, Loft us EV, Ehman EC et al. Computed tomography enterography detects intestinal wall changes and effects of treatment in patients with Crohn's disease. Clin Gastroenterol Hepatol 2011; 9: 679-83. e1.
13. Solem CA, Loftus EV, Fletcher JG et al. Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial. Gastrointest Endosc 2008; 68: 255-66.
14. Siddiki HA, Fidler JL, Fletcher JG et al. Prospective comparison of stateof- the-art MR enterography and CT enterography in small-bowel Crohn's disease. AJR Am J Roentgenol 2009; 193: 113-21.
15. Higgins PD, Caoili E, Zimmermann M et al. Computed tomographic enterography adds information to clinical management in small bowel Crohn's disease. Inflamm Bowel Dis 2007; 13: 262-8.
16. Hara AK, Alam S, Heigh RI et al. Using CT enterography to monitor Crohn's disease activity: a preliminary study. AJR Am J Roentgenol 2008; 190: 1512-6.
17. Bruining DH, Siddiki HA, Fletcher JG et al. Benefit of computed tomography enterography in Crohn's disease: effects on patient management and physician level of confidence. Inflamm Bowel Dis 2012; 18: 219-25.
18. Ordás I, Rimola J, Rodríguez S et al. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease. Gastroenterology 2014; 146: 374-82. e1.
19. Silverberg MS, Satsangi J, Ahmad T et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19: 5-36.
20. Siddiki H, Fletcher JG, Hara AK et al. Validation of a lower radiation computed tomography enterography imaging protocol to detect Crohn's disease in the small bowel. Inflamm Bowel Dis 2011; 17: 778-86.
21. Schindera ST, Nelson RC, DeLong DM et al. Multi-detector row CT of the small bowel: peak enhancement temporal window-initial experience 1. Radiology 2007; 243: 438-44.
22. Fletcher JG, Fidler JL, Huprich JE et al. Small-bowel imaging with CT and MR: Overview of techniques and indications. Applied Radiology 2012; 41: 18.
23. Panaccione R, Colombel J-F, Louis E et al. Evolving definitions of remission in Crohn's disease. Inflamm Bowel Dis 2013; 19: 1645-53.
24. Levesque BG, Sandborn WJ, Ruel J et al. Converging goals of treatment of inflammatory bowel disease from clinical trials and practice. Gastroenterology 2015; 148: 37-51 e1.
25. De Cruz P, Kamm MA, Prideaux L et al. Mucosal healing in Crohn's disease: a systematic review. Inflamm Bowel Dis 2012; 18: 758-77.
26. Baert F, Moortgat L, Van Assche G et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. Gastroenterology 2010; 138: 463-8.
27. Schnitzler F, Fidder H, Ferrante M et al. Mucosal healing predicts longterm outcome of maintenance therapy with infliximab in Crohn's disease. Inflamm Bowel Dis 2009; 15: 1295-301.
28. Rutgeerts P, Diamond RH, Bala M et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. Gastrointest Endosc 2006; 63: 433-42.
29. Colombel JF, Rutgeerts PJ, Sandborn WJ et al. Adalimumab induces deep remission in patients with Crohn's disease. Clin Gastroenterol Hepatol 2014; 12: 414-22. e5.
30. D'Haens G, Noman M, Baert F et al. Endoscopic healing aft er infliximab treatment for Crohn's disease provides a longer time to relapse. Inflamm Bowel Dis 2002; 63: A100.
31. Faubion WA, Fletcher JG, O'Byrne S et al. EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imaging. Am J Gastroenterol 2013; 108: 1891-900.
32. Minordi LM, Vecchioli A, Poloni G et al. Enteroclysis CT and PEG-CT in patients with previous small-bowel surgical resection for Crohn's disease: CT findings and correlation with endoscopy. Eur J Radiol 2009; 19: 2432-40.
33. Mao R, Gao X, Zhu Z-H et al. CT enterography in evaluating postoperative recurrence of Crohn's disease aft er ileocolic resection: complementary role to endoscopy. Inflamm Bowel Dis 2013; 19: 977-82.
34. Panes J, Bouhnik Y, Reinisch W et al. Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis 2013; 7: 556-85.
35. Rimola J, Rodríguez S, García-Bosch O et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease. Gut 2009; 58: 1113-20.
36. Oussalah A, Laurent V, Bruot O et al. Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease. Gut 2010; 59: 1056-65.
37. Steward MJ, Punwani S, Proctor I et al. Non-perforating small bowel Crohn's disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index. Eur J Radiol 2012; 81: 2080-8.
38. Rimola J, Ordás I, Rodriguez S et al. Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis 2011; 17: 1759-68.
39. Menys A, Atkinson D, Odille F et al. Quantified terminal ileal motility during MR enterography as a potential biomarker of Crohn's disease activity: a preliminary study. Eur J Radiol 2012; 22: 2494-501.